$10.94
19.56% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US28531P1030
Symbol
ECOR

electroCore, Inc. Stock price

$10.94
+2.90 36.07% 1M
+3.54 47.84% 6M
+4.99 83.81% YTD
+4.71 75.55% 1Y
-2.90 20.98% 3Y
-12.74 53.79% 5Y
-286.51 96.32% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-2.66 19.56%
ISIN
US28531P1030
Symbol
ECOR
Sector

Key metrics

Market capitalization $70.53m
Enterprise Value $61.37m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.63
P/S ratio (TTM) P/S ratio 3.02
P/B ratio (TTM) P/B ratio 7.53
Revenue growth (TTM) Revenue growth 74.10%
Revenue (TTM) Revenue $23.33m
EBIT (operating result TTM) EBIT $-13.03m
Free Cash Flow (TTM) Free Cash Flow $-8.86m
Cash position $14.48m
EPS (TTM) EPS $-1.82
P/E forward negative
P/S forward 3.42
EV/Sales forward 3.01
Short interest 1.04%
Show more

Is electroCore, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

electroCore, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a electroCore, Inc. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a electroCore, Inc. forecast:

Buy
100%

Financial data from electroCore, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
23 23
74% 74%
100%
- Direct Costs 3.89 3.89
66% 66%
17%
19 19
76% 76%
83%
- Selling and Administrative Expenses 29 29
14% 14%
123%
- Research and Development Expense 2.66 2.66
54% 54%
11%
-12 -12
40% 40%
-51%
- Depreciation and Amortization 1.16 1.16
23% 23%
5%
EBIT (Operating Income) EBIT -13 -13
37% 37%
-56%
Net Profit -13 -13
38% 38%
-54%

In millions USD.

Don't miss a Thing! We will send you all news about electroCore, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

electroCore, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place in New York City on November 21, 2024.
Neutral
Seeking Alpha
2 days ago
electroCore, Inc. (NASDAQ:ECOR ) Q3 2024 Earnings Call Transcript November 13, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO & Director Joshua Lev - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the electroCore Third Quarter 2024 Earnings Conference Call.
Neutral
GlobeNewsWire
2 days ago
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales
More electroCore, Inc. News

Company Profile

electroCore, Inc. is a commercial stage medical device company, which engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats, and Thomas J. Errico in September 2005 and is headquartered in Basking Ridge, NJ.

Head office United States
CEO Daniel Goldberger
Employees 68
Founded 2005
Website www.electrocore.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today